Please login to the form below

Not currently logged in
Email:
Password:

Amgen appoints Wanda Austin to its Board

She will also serve as a member of the firm's audit committee

Amgen has appointed Wanda Austin to its board of directors and as a member of its audit committee and corporate responsibility and compliance committee.

Austin most recently retired from her role as president and chief executive officer of space programme The Aerospace Corporation, where she has served from 2008 to 2016.

Robert Bradway, chairman and chief executive officer, Amgen, said: “We are pleased to welcome Dr Wanda Austin to Amgen’s board.

“Wanda’s deep experience in long-cycle technology and engineering settings and her senior leadership experience will be invaluable to Amgen.”

The addition of Austin will see Amgen’s board comprise of 14 directors, 13 of whom are independent of the company.

2nd November 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics